FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19 Posted byMatthew Woodruff September 17, 2021 Leave a comment on FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19 An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health official…